Strategies to Increase the Value of Drug Therapy
Strategies to Increase the Value of Drug Therapy Edit
Date: Tuesday, May 12
Time: 1:00 PM EST / 10:00 AM PST
Value is a concept that concerns all healthcare stakeholders.
Five Key Questions:
1. Do expensive drugs work good enough to support their price and deliver true value?
2. How can pharmaceutical value be integrated into therapeutic decisions
3. Can a single pharmaceutical value proposition be used for all stakeholders?
4. How can you balance the benefits obtained from a drug therapy with the costs to obtain them?
5. What decision-support tools can be used to promote high-value cancer drug therapy?
- Define value-based pharmaceutical care
- Gain an appreciation for different perceptions of value by key stakeholders in health care (providers, payers, patients, manufacturers)
- Increase awareness of strategies and decision-support tools to increase the value of cancer drug therapy (guidelines, pathways, drug class innovator reference, scorecards, etc)
Jim M. Koeller, MS, Professor, The University of Texas at Austin, Center for Pharmacoeconomic Studies, and the UT Health
Jim Koeller is Professor at the Center for Pharmacoeconomic Studies and holds the Eli Lilly/CR Sublett Endowed Fellowship in Pharmacy at the University of Texas at Austin College of Pharmacy. He is Adjoint Professor of Medicine and Oncology at the University of Texas Health Science Center at San Antonio. He previously worked in the Department of Human Oncology at Wisconsin Comprehensive Cancer Center, Madison, where he coordinated the Phase I Drug Development Program. Jim has published more than 250 articles, abstracts, and book chapters in the areas of oncology practice, pharmacoeconomics, new drug development, and supportive care for the cancer patient. In addition, he has made more than 500 presentations related to oncology, supportive care, pharmacoeconomics, cancer disease management, pathway development and management, and healthcare economics.